Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec 31;19(1):2177484.
doi: 10.1080/15476278.2023.2177484.

The Role of Gasdermin-D-Mediated Pyroptosis in Organ Injury and Its Therapeutic Implications

Joud Mulla  1 , Rohan Katti  1 , Melanie J Scott  1
Affiliations
Review

The Role of Gasdermin-D-Mediated Pyroptosis in Organ Injury and Its Therapeutic Implications

Joud Mulla et al. Organogenesis. .

Abstract

Gasdermin-D (GSDMD) belongs to the Gasdermin family (GSDM), which are pore-forming effector proteins that facilitate inflammatory cell death, also known as pyroptosis. This type of programmed cell death is dependent on inflammatory caspase activation, which cleaves gasdermin-D (GSDMD) to form membrane pores and initiates the release of pro-inflammatory cytokines. Pyroptosis plays an important role in achieving immune regulation and homeostasis within various organ systems. The role of GSDMD in pyroptosis has been extensively studied in recent years. In this review, we summarize the role of GSDMD in cellular and organ injury mediated by pyroptosis. We will also provide an outlook on GSDMD therapeutic targets in various organ systems.

Keywords: GSDMD; Gasdermin-D; inflammsome; organ injury; pyroptosis.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the authors.

Figures

Figure 1.
Figure 1.
GSDMD contributes to organ injury regulation through different pathways: caspase-1, ASC and NLRP3; TLR4-NFκB pathway; Gasdermin-D cleavage, IL1β and IL18 release.
See this image and copyright information in PMC

References

    1. Guo H, Callaway J, Ting JY . Inflammasomes: mechanism of action, role in disease, and therapeutics. Nat Med. 2015;21:677–14. 10.1038/nm.3893. - DOI - PMC - PubMed
    1. Zheng D, Liwinski T, Elinav E.. Inflammasome activation and regulation: toward a better understanding of complex mechanisms. Cell Discov. 2020;6:36. 10.1038/s41421-020-0167-x. - DOI - PMC - PubMed
    1. Sun Q, Fan J, Billiar TR, et al. Inflammasome and autophagy regulation - a two-way street. Mol Med. 2017;23:188–95. 10.2119/molmed.2017.00077. - DOI - PMC - PubMed
    1. Krakauer T. Inflammasomes, autophagy, and cell death: the Trinity of innate host defense against intracellular bacteria. Mediators Inflamm. 2019;2471215:1–10. 10.1155/2019/2471215. - DOI - PMC - PubMed
    1. Swanson KV, Deng M, Ting JP-Y. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat. Rev. Immunol. 2019;8:477–89. 10.1038/s41577-019-0165-0. - DOI - PMC - PubMed

LinkOut - more resources